Therapeutic quinolone compounds with 5-HT-antagonistic properties

Details for Australian Patent Application No. 2002348559 (hide)

Owner ASTRAZENECA AB

Inventors Horchler, Carey; Sohn, Daniel; Pierson, Edward; Davenport, Timothy; Chapdelaine, Marc; Haeberlein, Markus; McCauley, John

Agent Freehills

Pub. Number AU-A-2002348559

PCT Number PCT/SE02/01987

PCT Pub. Number WO2003/037871

Priority 0103648-2 01.11.01 SE

Filing date 1 November 2002

Wipo publication date 12 May 2003

International Classifications

C07D 215/42 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 031/4025 - not condensed and containing further heterocyclic rings, e.g. cromakalim

C07D 215/48 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/233 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 207/14 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 241/04 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 243/08 Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

C07D 265/30 Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 031/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 031/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 031/5377

A61P 001/00 Drugs for disorders of the alimentary tract or the digestive system

A61P 003/04 Drugs for disorders of the metabolism

A61P 005/00 Drugs for disorders of the endocrine system

A61P 015/00 Drugs for genital or sexual disorders

A61P 021/02 Drugs for disorders of the muscular or neuromuscular system

A61P 025/14 Drugs for disorders of the nervous system

A61P 025/20 Drugs for disorders of the nervous system

A61P 025/22 Drugs for disorders of the nervous system

A61P 025/24 Drugs for disorders of the nervous system

A61P 025/28 Drugs for disorders of the nervous system

A61P 043/00 Drugs for specific purposes, not provided for in groups

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): 0103648-2 01.11.01 SE

10 July 2003 Application Open to Public Inspection

  Published as AU-A-2002348559

18 May 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002348560-Therapeutic quinoline compounds with 5-HT-antagonistic properties

2002348558-METHOD AND ARRANGEMENT IN A SHORTEST PATH SEARCH SYSTEM